AOA 2025: Perfluorohexyloctane demonstrates early symptom relief and patient satisfaction
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
CIME 2025: What you missed in presbyopia tips, tricks, and updates
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO, provided their insights during CIME 2025 on May 4.
AAOpt: Presbyopia-correcting CSF-1 demonstrates consistent pupil restriction
CSF-1 (0.4% pilocarpine HCl), a presbyopia-correcting drop candidate from Orasis, demonstrated consistent pupil restriction, which also suggests neuroadaptation in patients with presbyopia to the drop over time.